Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
Threshold Pharmaceuticals to Present Updated Data From Phase 2b Clinical Trial of TH-302 in Combination With Gemcitabine in Advanced Pancreatic Cancer at ESMO 2012 Congress
Threshold Pharmaceuticals to Present Updated Data From Phase 2b Clinical Trial of TH-302 in Combination With Gemcitabine in Advanced Pancreatic Cancer at ESMO 2012 Congress